David Blaine Ridley

David Blaine Ridley

Professor of the Practice of Economics

External Address: 
100 Fuqua Drive, Durham, NC 27708-0120
Internal Office Address: 
Duke Box 90120, 100 Fuqua Drive, Durham, NC 27708-0120
(919) 660-3784

David Ridley is the Faculty Director of Health Sector Management at Duke University’s Fuqua School of Business. In his research, he examines innovation and pricing in health care. David was the lead author of the paper proposing the priority review voucher program which became law in 2007 and created a market of more than a billion dollars for drug development for neglected diseases. He was the principal investigator on a grant from the Bill & Melinda Gates Foundation for 2018 to 2020. He teaches courses on health care economics, policy, and strategy to graduate students. He received a PhD in economics from Duke University.


  • Ph.D., Duke University 2001
  • M.A., Duke University 1995
  • B.A., University of Missouri, Columbia 1993

Kyle, M. K., D. B. Ridley, and S. Zhang. “Strategic interaction among governments in the provision of a global public good.” Journal of Public Economics 156 (December 1, 2017): 185–99. https://doi.org/10.1016/j.jpubeco.2017.10.009. Full Text Open Access Copy

Ridley, David B., Jeffrey L. Moe, and Nick Hamon. “A Voucher System To Speed Review Could Promote A New Generation Of Insecticides To Fight Vector-Borne Diseases.Health Affairs (Project Hope) 36, no. 8 (August 2017): 1461–68. https://doi.org/10.1377/hlthaff.2016.1640. Full Text

Yurukoglu, A., E. Liebman, and D. B. Ridley. “The role of government reimbursement in drug shortages.” American Economic Journal: Economic Policy 9, no. 2 (May 1, 2017): 348–82. https://doi.org/10.1257/pol.20160035. Full Text Open Access Copy

Ridley, D. B., and S. Zhang. “Regulation of price increases.” International Journal of Industrial Organization 50 (January 1, 2017): 186–213. https://doi.org/10.1016/j.ijindorg.2016.11.004. Full Text

Ridley, David B. “Priorities for the Priority Review Voucher.The American Journal of Tropical Medicine and Hygiene 96, no. 1 (January 2017): 14–15. https://doi.org/10.4269/ajtmh.16-0600. Full Text Open Access Copy

Basu, Anirban, Kirsten Axelsen, David C. Grabowski, David O. Meltzer, Daniel Polsky, David B. Ridley, Daniel Wiederkehr, and Tomas J. Philipson. “Real-World Data: Policy Issues Regarding their Access and Use.Medical Care 54, no. 12 (December 2016): 1038–44. https://doi.org/10.1097/mlr.0000000000000603. Full Text

Basu, Anirban, Kirsten Axelsen, David C. Grabowski, David O. Meltzer, Daniel Polsky, David B. Ridley, Daniel Wiederkehr, and Tomas J. Philipson. “Real-World Data: Responses to Zito and Doshi.Medical Care 54, no. 12 (December 2016): 1048–49. https://doi.org/10.1097/mlr.0000000000000655. Full Text

Ridley, David B., and Su Zhang. “Regulation of Price Increases,” August 22, 2016.

Ridley, David B., and Stephane A. Régnier. “The Commercial Market For Priority Review Vouchers.Health Affairs (Project Hope) 35, no. 5 (May 2016): 776–83. https://doi.org/10.1377/hlthaff.2015.1314. Full Text

Ridley, David B., Jennifer Dent, and Christopher Egerton-Warburton. “Efficacy of the Priority Review Voucher Program.Jama 315, no. 15 (April 2016): 1659–60. https://doi.org/10.1001/jama.2016.0377. Full Text


Selected Grants

Transforming the Market to Address Antimicrobial Resistance awarded by Schmidt Futures (Advisor). 2020 to 2021

GHTC R&D Mapping awarded by PATH (Principal Investigator). 2016 to 2017

Determinants and Consequences of Alcohol Consumption awarded by National Institutes of Health (Investigator). 2005 to 2011